White v Novartis Pharmaceuticals Corp.

Filing 133

ORDER signed by Judge William B. Shubb on 8/18/2010 GRANTING defendant Novartis Pharmaceuticals' 131 Request to Seal Documents. Exhibit 4 to 128 Declaration of Gary I. Rubin and Exhibits 1,5,6, and 7 for 130 Declaration of Martin Calhoun is to be maintained UNDER SEAL. These Exhibits shall remain SEALED until further Order of Court. (Marciel, M)

Download PDF
White v Novartis Pharmaceuticals Corp. Doc. 133 James A. Bruen (State Bar No. 43880) (jbruen@fbm.com) Sandra A. Edwards (State Bar No. 154578) (sedwards@fbm.com) FARELLA BRAUN & MARTEL LLP 235 Montgomery Street, 17th Floor San Francisco, CA 94104 Telephone: (415) 954-4400 Facsimile: (415) 954-4480 Katharine R. Latimer (admitted pro hac vice) (klatimer@hollingsworthllp.com) Martin C. Calhoun (admitted pro hac vice) (mcalhoun@hollingsworthllp.com) HOLLINGSWORTH LLP 1350 I Street, N.W. Washington, DC 20005 Telephone: (202) 898-5800 Facsimile: (202) 682-1639 Attorneys for Defendant NOVARTIS PHARMACEUTICALS CORPORATION UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA CHERYL J. WHITE, SUCCESSOR TO WILLIAM WHITE, Plaintiff, v. NOVARTIS PHARMACEUTICALS CORPORATION, Defendant. Case No. 2:06-CV-00665-WBS-GGH Complaint Filed: March 29, 2006 Trial Date: November 16, 2010 ORDER TO SEAL DOCUMENTS The Court, having considered, pursuant to Civil Local Rule 141, the request by defendant Novartis Pharmaceuticals Corporation ("NPC") to seal certain exhibits upon which NPC relies in support of NPC's Opposition to Plaintiff's Motion for Sanctions to Strike Defendant's Pleadings Dockets.Justia.com and for Further Relief Pursuant to Findings Made by Order of the MDL Court (filed August 16, 2010) (DE #129), and for good cause shown, hereby grants NPC's request and orders that the following documents be maintained under seal until further order of the Court: A. Exhibit 4 to Declaration of Gary I. Rubin in Support of NPC's Opposition to Plaintiff's Motion for Sanctions to Strike Defendant's Pleadings and for Further Relief Pursuant to Findings Made by Order of the MDL Court (DE #128). Exhibit 4: 10/29/03 Core Team Material Clearance Form (ZA-0587648). This document shall be maintained by the Court under seal. B. Exhibits 1, 5, 6, and 7 to Declaration of Martin Calhoun in Support of NPC's Opposition to Plaintiff's Motion for Sanctions to Strike Defendant's Pleadings and for Further Relief Pursuant to Findings Made by Order of the MDL Court (DE #130). Exhibit 1: 4/15/10 Declaration of Gary I. Rubin with Attached Exhibits. This document shall be maintained by the Court under seal. Exhibit 5: Excerpts of the Transcript of the 10/15/08 Deposition of Robyn Sterner. This document shall be maintained by the Court under seal. Exhibit 6: Excerpts of the Transcript of the 1/8/10 Deposition of Michelle Laties. This document shall be maintained by the Court under seal. Exhibit 7: Excerpts of the Transcript of the 8/5/08 Deposition of Margaret Dean. This document shall be maintained by the Court under seal. DATED: August 18, 2010 SO ORDERED: Date: August 17, 2010 Respectfully submitted, /s/ Martin C. Calhoun Katharine R. Latimer (admitted pro hac vice) (klatimer@hollingsworthllp.com) Martin C. Calhoun (admitted pro hac vice) (mcalhoun@hollingsworthllp.com) HOLLINGSWORTH LLP 1350 I Street, N.W. Washington, DC 20005 Telephone: (202) 898-5800 Facsimile: (202) 682-1639 James A. Bruen (State Bar No. 43880) (jbruen@fbm.com) Sandra A. Edwards (State Bar No. 154578) (sedwards@fbm.com) FARELLA BRAUN & MARTEL LLP 235 Montgomery Street, 17th Floor San Francisco, CA 94104 Telephone: (415) 954-4400 Facsimile: (415) 954-4480 Attorneys for Defendant Novartis Pharmaceuticals Corporation

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?